CClinicalTrials.gg
Sign In
Status unknownNCT00188110Updated Jan 9, 2007

Performance of the Water-Enema Computed Tomography (WE-CT)

An interventional study of Water-Enema Computed Tomography in Colon Cancer, sponsored by University Hospital, Angers. Status unknown at 5 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2007-01-09.

Sponsored by University Hospital, Angers · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Sep 2005), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The WE-CT is an innovative and easy practice imaging technique of colon tumors; it is based on the colon distension by a high volume of warm water and a multidetector CT acquisition after IV (intravenous) contrast, allowing image analysis including the wall thickness and enhancement, the pericolic adjacent spaces and the entire abdomen.

The goal of the study is the evaluation of its performances for the diagnosis of colon tumors.

02

Conditions studied

  • Colon Cancer

Browse trials for

Keywords

  • Water-Enema Computed Tomography
  • colon tumor
  • coloscopy
  • suspicion of colon tumor
  • coloscopy or surgery
03

In context

Colonic Neoplasms

1,432 studies on the registry are indexed under Colonic Neoplasms; 357 are open to participants now.

This study's enrollment of 200 is above the median of 90 across 1,034 interventional studies indexed under Colonic Neoplasms.

Browse Colonic Neoplasms studies →

Lead sponsor

University Hospital, Angers is the lead sponsor of 464 studies on the registry; 116 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Written informed consent
  • WE-TC indication for colon tumor suspicion
  • Age > 18 years

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Patients under 65 years old and for whom the only WE-TC indication is familial antecedents of colon tumor, without clinical or para-clinical personal signs for this pathology
  • Infected sigmoid diverticulosis
  • Occlusive syndrome
  • Anesthesia contraindications
  • Anal incontinence
  • Renal insufficiency (creatinine > 150 micromol/L)
  • Iode allergy
  • Visceralgine contraindications
  • Scania contraindications
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
200 participants

Interventions

  • ProcedureWater-Enema Computed Tomography
06

What researchers measure

Primary outcomes

  1. To evaluate the performances of the WE-CT in patients suspected of having a colon tumor

Secondary outcomes

  1. To show the CT findings in case of colon tumor and its pitfalls

  2. To demonstrate the advantages of the WE-CT compared to the CT and magnetic resonance (MR) colonography for the diagnosis and local staging of colon tumors

07

Study locations

3 of 5 sites recruiting
  • UH of Angers
    Angers, 49033, France
    • Christophe Aube, MD · Contact · chaube@chu-angers.fr · 00-2-41-35-42-76
    • Christophe Aube, MD · Principal investigator
    • Catherine Ridereau, MD · Sub investigator
    • Pascal Burtin, MD · Sub investigator
    • Jean Boyer, MD · Sub investigator
    Recruiting
  • UH of Besancon
    Besancon, 25030, France
    Active, not recruiting
  • UH of Lyon
    Lyon, 69003, France
    • Jean Valette, MD · Contact · jean.valette@chu-lyon.fr · 00-4-72-11-75-40
    • Pierre Jean Valette, MD · Principal investigator
    • Christophe Beziat, MD · Sub investigator
    • Frank Pilleul, MD · Sub investigator
    • Jérôme Dumortier, MD · Sub investigator
    • François Bailly, MD · Sub investigator
    Recruiting
  • UH of Montpellier
    Montpellier, 34295, France
    Active, not recruiting
  • UH of Rennes
    Rennes, 35033, France
    • Yves Gandon, MD · Contact · yves-gandon@chu-rennes.fr · 00-2-99-28-43-67
    • Yves Gandon, MD · Principal investigator
    • Damien Olivié, MD · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00188110
Lead sponsor
University Hospital, Angers
Collaborators
Ministry of Health, France
First posted
Sep 16, 2005
Start date
Mar 2003
Last update
Jan 9, 2007

Study contacts

Christophe Aube, MD
Contact
chaube@chu-angers.fr
00-2-41-35-42-76
Christophe Aube, MD
principal investigator · UH of Angers
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2005. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Colonic Neoplasms→

Other studies from this sponsor

University Hospital, Angers

Start the discussion